NASDAQ: DTIL
Precision Biosciences Inc Stock Ownership - Who owns Precision Biosciences?

Insider buying vs selling

Have Precision Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael AmorosoPresident and CEO2025-11-033,409$6.49
$22.12kSell
Dario ScimecaGeneral Counsel and Secretary2025-11-03665$6.49
$4.32kSell
John Alexander KellyChief Financial Officer2025-11-031,303$6.49
$8.46kSell
Stanley FrankelDirector2025-09-262,700$4.97
$13.42kBuy
Melinda BrownDirector2025-09-221,400$4.89
$6.85kBuy
John Alexander KellyChief Financial Officer2025-07-0314,827$4.26
$63.16kSell
Melinda BrownDirector2025-06-251,682$4.14
$6.96kBuy
Kevin BuehlerDirector2025-06-255,076$4.16
$21.12kBuy
Melinda BrownDirector2025-03-261,839$4.75
$8.74kBuy
Kevin BuehlerDirector2025-03-264,523$4.67
$21.12kBuy

1 of 3

DTIL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DTIL insiders and whales buy or sell their stock.

DTIL Shareholders

What type of owners hold Precision Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pharma Ag Novartis93.59%12,407,440$62.29MInsider
Venbio Global Strategic Fund LP32.17%4,265,141$21.41MInsider
Derek Jantz30.59%4,055,174$20.36MInsider
Fmr LLC28.20%3,738,248$18.77MInsider
Matthew R. Kane15.27%2,024,438$10.16MInsider
Bleichroeder LP8.11%1,075,000$5.40MInstitution
Lynx1 Capital Management LP7.86%1,042,596$5.23MInstitution
Tang Capital Management LLC4.93%653,649$3.28MInstitution
Vanguard Group Inc3.72%492,596$2.47MInstitution
Renaissance Technologies LLC1.48%196,177$984.81kInstitution

1 of 3

DTIL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DTIL14.48%85.52%Net SellingNet Selling
LITS27.59%52.07%Net BuyingNet Buying
SNTI18.58%81.42%Net Buying
NRXP7.36%92.64%Net Buying
CALC12.32%87.68%Net BuyingNet Buying

Precision Biosciences Stock Ownership FAQ

Who owns Precision Biosciences?

Precision Biosciences (NASDAQ: DTIL) is owned by 35.07% institutional shareholders, 207.17% Precision Biosciences insiders, and 0.00% retail investors. Pharma Ag Novartis is the largest individual Precision Biosciences shareholder, owning 12.41M shares representing 93.59% of the company. Pharma Ag Novartis's Precision Biosciences shares are currently valued at $59.06M.

If you're new to stock investing, here's how to buy Precision Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.